Quintiles plans more Prime Sites in UK

Quintiles is considering setting up at least two more Prime Sites in the UK to make the most of what it regards as a still fertile environment for clinical trials. The US-based biopharmaceutical services company established the first of its international network of Prime Sites at Queen Mary, University of London in 2007. The company recently gave a further vote of confidence to the UK as a key location for clinical research by investing in a clinical research facility – part of the new William Harvey Heart Centre – at the same site.

Continue Reading